Deutsche Bank
ODT

Deutsche Bank’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Deutsche Bank’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-60,901
Closed -$82K – 4355
2021
Q4 		$82K Hold
60,901
– – ﹤0.01% 3787
2021
Q3 		$177K Sell
60,901
-142,062
-70% -$472K ﹤0.01% 3630
2021
Q2 		$709K Buy
202,963
+131,381
+184% +$451K ﹤0.01% 3004
2021
Q1 		$245K Sell
71,582
-2,130
-3% -$40.3K ﹤0.01% 3527
2020
Q4 		$1.42M Buy
73,712
+3,700
+5% +$57.1K ﹤0.01% 2190
2020
Q3 		$940K Buy
70,012
+63,373
+955% +$1.8M ﹤0.01% 2238
2020
Q2 		$281K Buy
6,639
+3,232
+95% +$105K ﹤0.01% 2946
2020
Q1 		$94K Sell
3,407
-6,545
-66% -$191K ﹤0.01% 3280
2019
Q4 		$321K Buy
9,952
+2,119
+27% +$65.7K ﹤0.01% 2961
2019
Q3 		$203K Buy
7,833
+1,829
+30% +$61.2K ﹤0.01% 3186
2019
Q2 		$219K Sell
6,004
-2,501
-29% -$59.9K ﹤0.01% 3763
2019
Q1 		$186K Sell
8,505
-290
-3% -$5.07K ﹤0.01% 4048
2018
Q4 		$123K Sell
8,795
-6,519
-43% -$102K ﹤0.01% 4123
2018
Q3 		$297K Buy
15,314
+2,184
+17% +$44.5K ﹤0.01% 4056
2018
Q2 		$290K Buy
13,130
+4,394
+50% +$102K ﹤0.01% 4124
2018
Q1 		$184K Buy
+8,736
New +$206K ﹤0.01% 4235

Other funds holding ODT

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Deutsche Bank's ODT Position: Q1 2022 in Review

Deutsche Bank sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 60,901 shares — an estimated $82K sold.

Deutsche Bank first reported a position in ODT in Q1 2018 and held it in 16 quarters. The position peaked at $1.42M in Q4 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

  • Deutsche Bank reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Deutsche Bank sold 60,901 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $82K.
  • Deutsche Bank first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 16 quarters.
  • Deutsche Bank's Odonate Therapeutics, Inc. Common Stock position peaked at $1.42M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Deutsche Bank's 13F filing for Q1 2022, filed 13 May 2022.